8.785USD-3.57%Mkt Cap: 1.94B USDP/E: —Last update: 2026-06-01
Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation techno…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.94B USD
Enterprise Value1.39B USD
Revenue (TTM)52.04M USD
Gross Profit45.38M USD
Net Income (TTM)-265.94M USD
Revenue/Share0.2590 USD
Last Price8.785 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees325
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS67576A1007
Valuation
P/E (Trailing)—
P/E (Forward)-5.90
PEG—
EV/EBITDA-4.71
EV/Revenue26.67
P/S37.91
P/B2.97
EPS (TTM)-1.44
EPS (Forward)-1.53
52W Range
6.23025% of range16.44
52W High16.44 USD
52W Low6.230 USD
Profitability
Gross Margin87.35%
Oper. Margin-865.46%
EBITDA Margin0.00%
Profit Margin-511.90%
ROE-40.64%
ROA-32.91%
Growth
Revenue Growth0.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-204.88M USD
CapEx (TTM)12.01M USD
FCF Margin-285.87%
FCF Yield-7.66%
Net Debt-587.24M USD
Net Debt/EBITDA1.99
Balance Sheet
Debt/Equity0.12
Current Ratio14.81
Quick Ratio14.49
Book Value/Sh3.030 USD
Cash/Share3.045 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)26.00 USD
Target Range18.00 USD – 34.00 USD
# Analysts11
Ownership
Shares Out.218.96M
Float184.63M
Insiders0.87%
Institutions95.67%
Short Interest
Short Ratio8.5d
Short % Float13.36%
Short % Out.11.32%
Shares Short24.78M
Short (prev mo.)24.53M
Technical
SMA 508.841 (-0.6%)
SMA 20010.78 (-18.5%)
Beta0.93
S&P 52W Chg27.94%
Avg Vol (30d)2.67M
Avg Vol (10d)2.77M
Technical Indicators
RSI (14)53.9
MACD-0.1597
MACD Signal-0.1538
MACD Hist.-0.0059
BB Upper10.26 USD
BB Middle8.991 USD
BB Lower7.727 USD
BB Width28.12%
ATR (14)0.4431 USD
Vol Ratio (20d)0.40x